VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,248,463 | -10.6% | 46,394 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $1,396,923 | -6.9% | 46,394 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $1,500,846 | +12.9% | 46,394 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,329,652 | +23.9% | 46,394 | +4.3% | 0.01% | +16.7% |
| Q3 2022 | $1,073,000 | -49.8% | 44,500 | -43.0% | 0.01% | -40.0% |
| Q2 2022 | $2,139,000 | -30.8% | 78,132 | -3.0% | 0.01% | -23.1% |
| Q1 2022 | $3,089,000 | +52.6% | 80,556 | +27.5% | 0.01% | +62.5% |
| Q4 2021 | $2,024,000 | +8.6% | 63,200 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,863,000 | -13.4% | 63,200 | -0.2% | 0.01% | -11.1% |
| Q2 2021 | $2,152,000 | -47.7% | 63,335 | -50.0% | 0.01% | -10.0% |
| Q1 2021 | $4,118,000 | +80.5% | 126,728 | +100.0% | 0.01% | -9.1% |
| Q4 2020 | $2,282,000 | -8.5% | 63,364 | -0.5% | 0.01% | -15.4% |
| Q3 2020 | $2,494,000 | +24.7% | 63,689 | +16.8% | 0.01% | +8.3% |
| Q2 2020 | $2,000,000 | +59.2% | 54,529 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $1,256,000 | -15.9% | 54,529 | +6.9% | 0.01% | 0.0% |
| Q4 2019 | $1,493,000 | +9.3% | 51,000 | -0.3% | 0.01% | 0.0% |
| Q3 2019 | $1,366,000 | +4.8% | 51,151 | +0.3% | 0.01% | 0.0% |
| Q2 2019 | $1,304,000 | +14.1% | 51,000 | 0.0% | 0.01% | +14.3% |
| Q1 2019 | $1,143,000 | +8.3% | 51,000 | +2.0% | 0.01% | 0.0% |
| Q4 2018 | $1,055,000 | +13.1% | 50,000 | -0.8% | 0.01% | +40.0% |
| Q3 2018 | $933,000 | -17.1% | 50,395 | -0.0% | 0.01% | -28.6% |
| Q2 2018 | $1,125,000 | +1.5% | 50,405 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,108,000 | -7.7% | 50,405 | -2.3% | 0.01% | 0.0% |
| Q4 2017 | $1,200,000 | -40.4% | 51,616 | -41.1% | 0.01% | -41.7% |
| Q3 2017 | $2,012,000 | +4.6% | 87,616 | +0.6% | 0.01% | 0.0% |
| Q2 2017 | $1,924,000 | -3.2% | 87,116 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $1,987,000 | +7.5% | 87,116 | -1.5% | 0.01% | 0.0% |
| Q4 2016 | $1,849,000 | -22.3% | 88,400 | -1.9% | 0.01% | -20.0% |
| Q3 2016 | $2,381,000 | -1.9% | 90,078 | +2.9% | 0.02% | -6.2% |
| Q2 2016 | $2,427,000 | – | 87,573 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |